Skip to content

Suzanne Turner

  • PhD
  • Senior Lecturer
  • University of Cambridge
  • 17h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 693CitationsNumber of citations received by Suzanne's publications. Updated daily.

Research interests

neuroblastomaT cellsLymphomaAnaplastic Lymphoma KinaseAnaplastic Large Cell Lymphoma

Co-authors (279)

  • Karen Pulford
  • Sabine Lagger

Publications (5)

  • ALK in neuroblastoma: Biological and therapeutic implications

    • Trigg R
    • Turner S
    N/AReaders
    0Citations
    Get full text
  • The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma

    • Schleussner N
    • Merkel O
    • Costanza M
    • et al.
    N/AReaders
    1Citations
    Get full text
  • The role of activator protein-1 (AP-1) family members in CD30-positive lymphomas

    • Garces de Los Fayos Alonso I
    • Liang H
    • Turner S
    • et al.
    N/AReaders
    0Citations
    Get full text
  • Treatment options for paediatric anaplastic large cell lymphoma (ALCL): Current standard and beyond

    • Prokoph N
    • Larose H
    • Lim M
    • et al.
    N/AReaders
    0Citations
    Get full text
  • Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis

    • Harrison S
    • Lennon R
    • Holly J
    • et al.
    N/AReaders
    5Citations
    Get full text

Professional experience

Senior Lecturer

University of Cambridge

July 2005 - Present

Research Associate

Babraham Institute

January 2000 - July 2005(6 years)

Research Associate

AstraZeneca Alderley Park

October 1999 - January 2000(3 months)

Education

PhD

Cancer Research UK Manchester Institute

October 1996 - September 1999(3 years)